- Home
- KRKR vs EVOK Comparison
KRKR vs EVOK Comparison
Compare KRKR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- EVOK
- Stock Information
- Founded
- KRKR 2010
- EVOK 2007
- Country
- KRKR China
- EVOK United States
- Employees
- KRKR N/A
- EVOK N/A
- Industry
- KRKR Business Services
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- EVOK Health Care
- Exchange
- KRKR Nasdaq
- EVOK Nasdaq
- Market Cap
- KRKR 6.6M
- EVOK 7.0M
- IPO Year
- KRKR 2019
- EVOK 2013
- Fundamental
- Price
- KRKR $3.22
- EVOK $4.94
- Analyst Decision
- KRKR
- EVOK
- Analyst Count
- KRKR 0
- EVOK 0
- Target Price
- KRKR N/A
- EVOK N/A
- AVG Volume (30 Days)
- KRKR 22.3K
- EVOK 40.0K
- Earning Date
- KRKR 12-31-2024
- EVOK 11-07-2024
- Dividend Yield
- KRKR N/A
- EVOK N/A
- EPS Growth
- KRKR N/A
- EVOK N/A
- EPS
- KRKR N/A
- EVOK N/A
- Revenue
- KRKR $41,654,350.00
- EVOK $8,617,036.00
- Revenue This Year
- KRKR $45.99
- EVOK $97.35
- Revenue Next Year
- KRKR $31.46
- EVOK $99.52
- P/E Ratio
- KRKR N/A
- EVOK N/A
- Revenue Growth
- KRKR N/A
- EVOK 100.35
- 52 Week Low
- KRKR $2.76
- EVOK $3.54
- 52 Week High
- KRKR $12.60
- EVOK $14.04
- Technical
- Relative Strength Index (RSI)
- KRKR 52.25
- EVOK 52.97
- Support Level
- KRKR $3.10
- EVOK $4.33
- Resistance Level
- KRKR $3.69
- EVOK $5.75
- Average True Range (ATR)
- KRKR 0.35
- EVOK 0.39
- MACD
- KRKR 0.06
- EVOK 0.12
- Stochastic Oscillator
- KRKR 70.43
- EVOK 47.98
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.